Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Different Doses of Indacaterol

ClinicalTrials.gov ID: NCT01079130

Public ClinicalTrials.gov record NCT01079130. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol

Study identification

NCT ID
NCT01079130
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
511 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2010 (Type not available)
Primary completion
Jul 2010 (Actual)
Completion
Not listed
Last update posted
Aug 19, 2011

Started 2010

United States locations

U.S. sites
71
U.S. states
26
U.S. cities
67
Facility City State ZIP Site status
Novartis Investigator Site Glendale Arizona 85306 —
Novartis Investigator Site Scottsdale Arizona 85251 —
Novartis Investigator Site Encinitas California 92024 —
Novartis Investigator Site Huntington Beach California 92647 —
Novartis Investigator Site Los Angeles California 90025 —
Novartis Investigator Site Los Angeles California 90048 —
Novartis Investigative Site Mission Viejo California 92691 —
Novartis Investigator Site Orange California 92868 —
Novartis Investigator Site Rancho Mirage California 92270 —
Novartis Investigator Site Rolling Hills Estates California 90274 —
Novartis Investigator Site San Diego California 92120 —
Novartis Investigator Site San Diego California 92123 —
Novartis Investigator Site San Jose California 95117 —
Novartis Investigator Site Stockton California 95207 —
Novartis Investigator Site Colorado Springs Colorado 80907 —
Novartis Investigator Site Denver Colorado 80230 —
Novartis Investigator Site Engelwood Colorado 80112 —
Novartis Investigator Site Lakewood Colorado 80401 —
Novartis Investigative Site Stamford Connecticut 06902 —
Novartis Investigative Site Waterbury Connecticut 06708 —
Novartis Investigative site Destin Florida 32541 —
Novartis Investigative Site Pensacola Florida 32503 —
Novartis Investigative Site Pensacola Florida 32514 —
Novartis Investigative Site Port Orange Florida 32127 —
Novartis Investigative Site Sarasota Florida 34233 —
Novartis Investigative Site Tamarac Florida 33321 —
Novartis Investigative Site Winter Park Florida 32789 —
Novartis Investigator Site Boise Idaho 83704 —
Novartis Investigator Site Normal Illinois 61761 —
Novartis Investigative Site Springfield Illinois 62703 —
Novartis Investigator Site Overland Park Kansas 66210 —
Novartis Investigative Site Louisville Kentucky 40215 —
Novartis Investigator Site Lafayette Louisiana 70503 —
Novartis Investigative Site Baltimore Maryland 21236 —
Novartis Investigator Site Columbia Maryland 21044 —
Novartis Investigative Site Wheaton Maryland 20902 —
Novartis Investigative Site North Dartmouth Massachusetts 02747 —
Novartis Investigative Site Minneapolis Minnesota 55402 —
Novartis Investigator Site Columbia Missouri 65203 —
Novartis Investigator Site Rolla Missouri 65401 —
Novartis Investigator Site St Louis Missouri 63141 —
Novartis Investigator Site Warrensburg Missouri 64093 —
Novartis Investigative Site Missoula Montana 59808 —
Novartis Investigator Site Bellevue Nebraska 68123 —
Novartis Investigator Site Boys Town Nebraska 68010 —
Novartis Investigative Site Ocean City New Jersey 07712 —
Novartis Investigative Site Skillman New Jersey 08558 —
Novartis Investigative Site Charlotte North Carolina 28207 —
Novartis Investigative Site Raleigh North Carolina 27607 —
Novartis Investigator Site Cadiz Ohio 43907 —
Novartis Investigative Site Columbus Ohio 43215 —
Novartis Investigative Site Maumee Ohio 43537 —
Novartis Investigator Site Oklahoma City Oklahoma 73103 —
Novartis Investigator Site Lake Oswego Oregon 97035 —
Novartis Investigative Site Medford Oregon 97504 —
Novartis Investigator Site Portland Oregon 97213 —
Novartis Investigative Site Erie Pennsylvania 16506 —
Novartis Investigative Site Phoenixville Pennsylvania 19460 —
Novartis Investigative Site Pittsburgh Pennsylvania 15243 —
Novartis Investigative Site Upland Pennsylvania 19013 —
Novartis Investigative Site Lincoln Rhode Island 02865 —
Novartis Investigative Site Charleston South Carolina 29414 —
Novartis Investigative site North Charleston South Carolina 29406 —
Novartis Investigator Site Austin Texas 78758 —
Novartis Investigator Site Dallas Texas 75231 —
Novartis Investigator Site El Paso Texas 79903 —
Novartis Investigator Site El Paso Texas 79925 —
Novartis Investigator Site Georgetown Texas 78628 —
Novartis Investigator Site North Richland Hills Texas 76180 —
Novartis Investigator Site Waco Texas 73712 —
Novartis Investigator Site Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01079130, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2011 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01079130 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →